Daclatasvir-d6
Purchase
Product Details
| Name | Daclatasvir-d6 |
|---|---|
| Product No. | SI040020 |
| Synonym(s) | BMS-790052-d6; Daklinza-d6; NATDAC-d6; Methyl [(2S)-1-{(2S)-2-[4-(4’-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-pyrrolidinyl]-1H-imidazol-4-yl}-4-biphenylyl)-1H-imidazol-2-yl]-1-pyrrolidinyl}-3-methyl-1-oxo-2-butanyl]carbamate |
| Category | Reference StandardsStable Isotopes |
| Alternate CAS No. | 1009119-64-5 (non-d) |
| Formula | C40H44D6N8O6 |
| Molecular Weight | 744.91 |
| Availability | Yes |
| Availability in Bulk | Yes |
| Purity | >95% |
| Isotropic Enrichment | >98% |
| Description | Hepatitis C |
| Comments | Reference Standards; Stable Isotopes; Metabolites |
| Datasheet(s) | SI040020_COA.pdf (47.121 KB) |